A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC.
Saved in:
| Title: | A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC. |
|---|---|
| Authors: | Burcher K; Duke Cancer Institute, Durham, NC 27710, USA., Karukonda P; Duke Cancer Institute, Durham, NC 27710, USA., Kelsey C; Duke Cancer Institute, Durham, NC 27710, USA., Mullikin T; Duke Cancer Institute, Durham, NC 27710, USA., Antonia SJ; Duke Cancer Institute, Durham, NC 27710, USA., Oduah EI; Duke Cancer Institute, Durham, NC 27710, USA. |
| Source: | Cancers [Cancers (Basel)] 2025 May 30; Vol. 17 (11). Date of Electronic Publication: 2025 May 30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
